Keyphrases
Lung Transplantation
100%
Idiopathic Pulmonary Fibrosis
23%
Artificial Stone
23%
Silicosis
23%
Transplantation
15%
Prospective Cohort Study
15%
Confidence Interval
13%
Lung Cancer
11%
BNT162b2 Vaccine
11%
Diagnostic Performance
10%
Pulmonary Infection
9%
SARS-CoV-2 Vaccine
9%
ISHLT
9%
Humoral Response
9%
Chronic Lung Allograft Dysfunction
9%
Bronchoscopy
8%
Prognostic Significance
8%
Bronchoalveolar Lavage
8%
Amyloidosis
8%
Endobronchial
8%
Mycobacterium Tuberculosis (M. tb)
8%
Pretransplant
8%
Transplanted Patients
7%
Combination Therapy
7%
Single-center Experience
7%
Endobronchial Brachytherapy
7%
Nontuberculous
7%
Mepolizumab
7%
Cryo
7%
Transbronchial Cryobiopsy
7%
International Symposium
7%
Lung Allograft
7%
Graft-versus-host Disease (GvHD)
7%
Antifibrotic
7%
Single Center
7%
Adenosine Deaminase
7%
Real-life Cohort
7%
Radiological Assessment
7%
Connective Tissue Disease
7%
Pulmonary Arterial Hypertension
7%
Retrospective Observational Study
7%
Consensus Document
7%
Cytomegalovirus
7%
Candidate Evaluation
7%
ICU Discharge
7%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
7%
Selection Criteria
7%
Stereotactic Body Radiation Therapy
7%
Israeli
7%
Hospital Discharge
7%
Medicine and Dentistry
Lung Transplantation
89%
Silicosis
23%
Idiopathic Pulmonary Fibrosis
22%
Transplantation
20%
Allograft
16%
Brain Natriuretic Peptide
15%
Biopsy
15%
Lung Cancer
15%
Amino Terminal Sequence
15%
Diagnosis
8%
Pulmonary Hypertension
8%
Bronchoscopy
8%
Amyloidosis
8%
Eosinophilic
8%
Antivirus Agent
7%
Cellular Immunity
7%
Systematic Review
7%
Pleura Effusion
7%
Graft Versus Host Reaction
7%
Allogeneic Hematopoietic Stem Cell Transplantation
7%
Immunotherapy
7%
Asthma
7%
Immunoglobulin G4 Related Disease
7%
Humoral Immunity
7%
Lung Infection
7%
Observational Study
7%
Meta-Analysis
7%
Connective Tissue Disease
7%
Adenosine Deaminase
7%
Severe Acute Respiratory Syndrome
7%
Combination Therapy
7%
Brachytherapy
7%
Cytomegalovirus
7%
Stem Cell Therapy
7%
Cytomegalovirus Infection
7%
Cohort Effect
7%
Mepolizumab
7%
Cell Transplantation
7%
Biological Marker
7%
Interstitial Lung Disease
7%
Randomized Controlled Trial
7%
Case Presentation
7%
Stereotactic Body Radiation Therapy
7%
Lung
7%
Hematopoietic Cell
7%
Anti-Inflammatory Drug
7%
Prospective Cohort Study
7%
Autoimmune Disease
7%
Disease
7%
Silo-Filler's Disease
6%